Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
CALL
Boston Properties
BXP
$11.1B
| $2.04M | ﹤0.01% |
35,500
+8,000
| +29% | +$416K |
|
3402
Beyond Meat
BYND
$238M
| $2.04M | ﹤0.01% |
5,245
+1,114
| +27% | +$424K |
|
3403
Cullinan Oncology
CGEM
$1.4B
| $2.03M | ﹤0.01% |
189,073
-55,480
| -23% | -$589K |
|
3404
Invivyd
IVVD
$284M
| $2.03M | ﹤0.01% |
1,935,875
+409,716
| +27% | +$523K |
|
3405
Bionano Genomics
BNGO
$13.8M
| $2.03M | ﹤0.01% |
+5,551
| New | +$2.51M |
|
3406
CALL
Axsome Therapeutics
AXSM
$10.4B
| $2.03M | ﹤0.01% |
+28,200
| New | +$2.08M |
|
3407
Thor Industries
THO
$4.01B
| $2.02M | ﹤0.01% |
19,551
+5,022
| +35% | +$424K |
|
3408
The Honest Company
HNST
$608M
| $2.02M | ﹤0.01% |
1,203,699
+1,098,297
| +1,042% | +$1.87M |
|
3409
Anavex Life Sciences
AVXL
$277M
| $2.02M | ﹤0.01% |
248,297
+169,649
| +216% | +$1.45M |
|
3410
PJT Partners
PJT
$4.67B
| $2.02M | ﹤0.01% |
+28,977
| New | +$2M |
|
3411
CALL
Lattice Semiconductor
LSCC
$16.2B
| $2.02M | ﹤0.01% |
+21,000
| New | +$1.81M |
|
|
PTVE
3412
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $2.02M | ﹤0.01% |
266,444
+142,837
| +116% | +$1.09M |
|
3413
Synaptics
SYNA
$3.72B
| $2.02M | ﹤0.01% |
23,616
+2,509
| +12% | +$218K |
|
|
TIXT
3414
DELISTED
TELUS International
TIXT
| $2.01M | ﹤0.01% |
+132,721
| New | +$2.31M |
|
|
PSTX
3415
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.01M | ﹤0.01% |
1,144,351
+168,739
| +17% | +$431K |
|
|
PVBC
3416
DELISTED
Provident Bancorp
PVBC
| $2.01M | ﹤0.01% |
243,136
+221,361
| +1,017% | +$1.67M |
|
|
BCYC
3417
Bicycle Therapeutics
BCYC
$294M
| $2.01M | ﹤0.01% |
78,759
+61,923
| +368% | +$1.44M |
|
3418
Virgin Galactic
SPCE
$446M
| $2.01M | ﹤0.01% |
25,894
-43,932
| -63% | -$3.48M |
|
3419
Bluerock Homes Trust
BHM
$35.4M
| $2.01M | ﹤0.01% |
124,495
+54,163
| +77% | +$933K |
|
3420
Star Holdings Shares of Beneficial Interest
STHO
$119M
| $2.01M | ﹤0.01% |
136,935
-44,147
| -24% | -$699K |
|
3421
PUT
IAMGOLD
IAG
$11.8B
| $2M | ﹤0.01% |
760,400
-280,400
| -27% | -$812K |
|
3422
PUT
XP
XP
$8.96B
| $1.99M | ﹤0.01% |
+85,000
| New | +$1.44M |
|
3423
CALL
Viking Therapeutics
VKTX
$3.75B
| $1.99M | ﹤0.01% |
123,000
-212,300
| -63% | -$4.45M |
|
|
INFN
3424
DELISTED
Infinera Corporation Common Stock
INFN
| $1.99M | ﹤0.01% |
411,858
-3,061,263
| -88% | -$16.8M |
|
3425
CALL
Warner Bros
WBD
$72.1B
| $1.99M | ﹤0.01% |
158,600
+115,500
| +268% | +$1.5M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.